320 related articles for article (PubMed ID: 22503544)
21. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
[TBL] [Abstract][Full Text] [Related]
22. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity.
Muñoz M; López-Oliva E; Pinilla E; Rodríguez C; Martínez MP; Contreras C; Gómez A; Benedito S; Sáenz-Medina J; Rivera L; Prieto D
Biochem Pharmacol; 2022 Jan; 195():114850. PubMed ID: 34822809
[TBL] [Abstract][Full Text] [Related]
23. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
24. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
25. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450/NADPH-dependent biosynthesis of 5,6-trans-epoxyeicosatrienoic acid from 5,6-trans-arachidonic acid.
Roy U; Joshua R; Stark RL; Balazy M
Biochem J; 2005 Sep; 390(Pt 3):719-27. PubMed ID: 15916533
[TBL] [Abstract][Full Text] [Related]
27. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.
Sun P; Lin DH; Yue P; Jiang H; Gotlinger KH; Schwartzman ML; Falck JR; Goli M; Wang WH
J Am Soc Nephrol; 2010 Oct; 21(10):1667-77. PubMed ID: 20595684
[TBL] [Abstract][Full Text] [Related]
28. Arachidonic acid cytochrome P450 epoxygenase pathway.
Spector AA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.
Wang MH; Smith A; Zhou Y; Chang HH; Lin S; Zhao X; Imig JD; Dorrance AM
Hypertension; 2003 Oct; 42(4):594-9. PubMed ID: 12939236
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 eicosanoids and cerebral vascular function.
Imig JD; Simpkins AN; Renic M; Harder DR
Expert Rev Mol Med; 2011 Mar; 13():e7. PubMed ID: 21356152
[TBL] [Abstract][Full Text] [Related]
31. Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancy.
Somani ST; Zeigler M; Fay EE; Leahy M; Bermudez B; Totah RA; Hebert MF
Life Sci; 2021 Jan; 264():118590. PubMed ID: 33069736
[TBL] [Abstract][Full Text] [Related]
32. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
Keserü B; Barbosa-Sicard E; Popp R; Fisslthaler B; Dietrich A; Gudermann T; Hammock BD; Falck JR; Weissmann N; Busse R; Fleming I
FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458
[TBL] [Abstract][Full Text] [Related]
33. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice.
Zhang B; Lai G; Liu X; Zhao Y
Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278
[TBL] [Abstract][Full Text] [Related]
34. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
35. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
[TBL] [Abstract][Full Text] [Related]
36. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide.
Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584
[TBL] [Abstract][Full Text] [Related]
37. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
[TBL] [Abstract][Full Text] [Related]
38. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
Deng Y; Edin ML; Theken KN; Schuck RN; Flake GP; Kannon MA; DeGraff LM; Lih FB; Foley J; Bradbury JA; Graves JP; Tomer KB; Falck JR; Zeldin DC; Lee CR
FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
[TBL] [Abstract][Full Text] [Related]
39. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
40. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D
Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
